Artificial Heart Pumps Save Three Teenagers, Bridge Them to Life-Saving Transplants

Three teenagers battling end-stage heart failure have been given a second chance at life after doctors at Bengaluru-headquartered Narayana Health successfully used advanced Ventricular Assist Devices (VADs) to keep them alive until donor hearts became available, marking a significant milestone in India's evolving paediatric cardiac care landscape.

The teenagers, who arrived at the hospital separately in extremely critical condition, faced slim chances of survival as their hearts had become too weak to sustain normal blood circulation. To stabilize them, doctors implanted VADs—mechanical pumps that support a failing heart by maintaining blood flow to vital organs while patients await transplantation.

The technology, widely used globally as a "bridge-to-transplant" therapy, proved lifesaving in all three cases. Unlike an artificial heart, a VAD works alongside the patient's existing heart, taking over much of the pumping function and buying crucial time until a suitable donor organ becomes available. The devices help ensure continuous circulation of oxygen-rich blood to critical organs, significantly improving survival chances for patients awaiting transplantation.

One teenager suffering from severe heart dysfunction and dangerous blood clots required a BiVAD , a specialised device that supports both sides of the heart. After spending 45 days on mechanical support, the patient successfully underwent a heart transplant and was discharged within weeks.

The second patient, diagnosed with dilated cardiomyopathy , a condition that weakens and enlarges the heart, was supported by a VAD for 28 days before receiving a donor heart.

The third teenager, a childhood cancer survivor who had previously lost a kidney to a tumour, spent 30 days on mechanical heart support before undergoing a successful transplant.

Despite persistent challenges surrounding organ donation and donor shortages, matching hearts were found for all three patients within 28 to 45 days , an outcome doctors described as remarkable given the often lengthy waiting periods associated with transplantation.

According to Dr. Shashiraj Subramanya H S , Head of Paediatric Cardiology at Narayana Health, the patients were at the very edge of survival when they arrived. He described the successful use of artificial heart pumps as a landmark moment for heart failure care in India.

Dr. Varun Shetty , Senior Consultant – Cardiac Surgery, said the achievement reflects years of effort to make advanced cardiac technologies accessible and affordable for Indian families. Dr. Riyan Sukumar Shetty , Director of Paediatric Intensive Care, noted that the VADs acted as lifesaving bridges until donor hearts became available.

Founded by renowned cardiac surgeon Dr. Devi Shetty and headquartered in Bengaluru , Narayana Health is among India's largest healthcare providers. The network operates a wide range of primary, secondary and super-speciality hospitals across India and the Caribbean, with a strong reputation in cardiac sciences, organ transplantation and advanced critical care .

The successful treatment of the three teenagers highlights not only the growing capabilities of India's heart transplant ecosystem but also the increasing availability of highly specialised therapies that were once limited to a handful of centres worldwide. It also underscores how advances in mechanical circulatory support, improved transplant coordination and expanding access to cutting-edge care are transforming outcomes for critically ill children across the country.